| Trial ID: | L3205 |
| Source ID: | NCT00530686
|
| Associated Drug: |
Islet Cell Transplantation
|
| Title: |
Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Islet Cell Transplantation|Type 1 Diabetes
|
| Interventions: |
DRUG: Islet cell transplantation
|
| Outcome Measures: |
Primary: 1)Presence or absence of hypoglycemic unawareness 2) To assess incidence of hypoglycemic episodes 3) To assess insulin requirements in patients who did not become insulin independent., 24 months | Secondary: To assess the achievement of insulin independence at 12 month and 24 month post transplant in patients who underwent allo islet cell transplantation., 12 months and 24 months
|
| Sponsor/Collaborators: |
Sponsor: Baylor Research Institute | Collaborators: Baylor Health Care System
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
1
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-07
|
| Completion Date: |
2017-04
|
| Results First Posted: |
|
| Last Update Posted: |
2017-04-24
|
| Locations: |
Annette C. & Harold C. Simmons Transplant Institute - Baylor University Medical Center, Dallas Texas, USA - Baylor All Saints Medical Center, Fort Worth Texas, USA, Dallas, Texas, 75246, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00530686
|
